← Stocks · BNGO record
Signal record & history · Trifecta Signals
Bionano has been flagged by the Trifecta screener 6 times since 2022. 4 signals confirmed; the median confirmed signal is down 99.8% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Apr 2022 · Latest Aug 2023 · Confirmed 4 of 6 Early · Latest close in the chart data: Thu, Nov 5, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since April 2022, Bionano has had six Early signals, four confirmed. Four of the four decided signals gained +10% within 90 days, and zero of four finished ahead of the S&P 500 since confirmation. Three signals carried a caution flag. Two Early signals never confirmed and count in no statistic.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for BNGO and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Bionano Genomics is classified in the Healthcare sector, Diagnostics & Research industry. With a market value of about $17 million, the company falls in the small-cap group.
Bionano Genomics’ standout Trifecta run followed a May 2023 confirmation, falling about 19% over the next 90 days. Bionano Genomics’ January 2023 signal, which landed in the Downtrend group, fell about 32% over the following 90 days. Classification adds texture: its latest signal was rated Low Quality, revenue was growing by about 35% at the time, and it sat in the mid-cap group when that signal fired.
BNGO closed Thursday, November 5 at $1.10, down 7.6% on the day. Over the past week, the shares have traded in a range between about $1.10 and $1.20.
